- Home
- ยป
- Our Products
- »
- Diabetic Medicine
Diabetic Medicine
Thyroxine Sodium 200 mcg
Minimum Order Quantity: 1 Bottle
Product Brochure
Strength | 200 mcg |
Packaging Size | 120 Tablets |
Packaging Type | Bottle |
Brand Name | THYRORISE 200 |
Manufacturer | Steris Healthcare Pvt Ltd |
Brand | THYRORISE 200 |
Composition | Thyroxine Sodium 200 mcg |
Shelf Life | 24 months |
Country of Origin | Made in India |
Thyroxine Sodium, commonly known as levothyroxine, is a synthetic form of the thyroid hormone used to treat hypothyroidism, a condition where the thyroid gland does not produce enough hormones. THYRORISE 200, with a dosage of 200mcg, helps restore normal hormone levels, improving various bodily functions and overall well-being.
How Does It Work?Thyroxine Sodium works by replacing or supplementing the thyroid hormone that is naturally produced by the thyroid gland. It plays a crucial role in regulating the body's metabolism, energy production, and growth. By increasing thyroid hormone levels, it helps improve symptoms of hypothyroidism, such as fatigue, weight gain, and depression.
Uses of THYRORISE 200- Hypothyroidism Treatment: Restores thyroid hormone levels in individuals with an underactive thyroid gland.
- Goiter Prevention: Helps reduce the size of an enlarged thyroid gland.
- Thyroid Cancer: Used as part of the treatment plan for certain types of thyroid cancer.
THYRORISE 200 is a medication containing 200mcg of Thyroxine Sodium. It is prescribed to patients with thyroid hormone deficiencies to help maintain normal thyroid hormone levels in the body.
Side Effects- Common Side Effects: Headache, sweating, nervousness, and irritability.
- Severe Side Effects: Chest pain, rapid or irregular heartbeat, and shortness of breath. Seek medical attention if these occur.
- Dosage Adherence: Always take THYRORISE 200 exactly as prescribed by your healthcare provider.
- Regular Monitoring: Regular blood tests are essential to monitor thyroid hormone levels and adjust dosage accordingly.
- Interactions: Inform your doctor about any other medications you are taking, as Thyroxine Sodium can interact with certain drugs.
Linagliptin (5mg), Dapagliflozin(10mg) and Metformin Hydrochloride (SR) (1000mg)
Product Brochure
Strength | 10 mg / 1000 mg |
Pack Size | 10*10 Tablets |
Packaging Size | 10*10 Tablets |
Brand | LINALIGLIP DAPAMET |
Manufacturer | Steris Healthcare Pvt Ltd |
Usage | To Treat Type 2 Diabetes |
Packaging Type | Box |
Pack Type | Strip |
LINALIGLIP DAPAMET is a potent combination therapy designed to manage type 2 diabetes effectively. With a synergistic blend of Linagliptin (5mg), Dapagliflozin (10mg), and Metformin Hydrochloride (SR) (1000mg), this medication helps regulate blood sugar levels while addressing multiple aspects of diabetes care. It is a comprehensive solution that enhances glycemic control, reduces insulin resistance, and minimizes the risk of complications associated with diabetes.
Key Benefits:
-
Comprehensive Glycemic Control
- The triple-action formula targets different pathways to maintain optimal blood sugar levels throughout the day.
-
Weight Management
- Dapagliflozin helps reduce excess body weight, a common issue in people with type 2 diabetes.
-
Cardiovascular Benefits
- Proven to lower the risk of cardiovascular events, such as heart attack and stroke, in diabetic patients.
-
Enhanced Insulin Sensitivity
- Metformin improves the body's response to insulin, reducing insulin resistance.
-
Convenience
- Combines three powerful diabetes medications into one tablet, reducing the need for multiple prescriptions and enhancing patient compliance.
LINALIGLIP DAPAMET works through a multi-pronged approach to diabetes management:
- Linagliptin: Inhibits the DPP-4 enzyme, allowing incretin hormones to stimulate insulin release and reduce glucagon levels, thereby lowering blood sugar levels.
- Dapagliflozin: Inhibits SGLT2 in the kidneys, promoting glucose excretion through urine, which helps in both glycemic control and weight loss.
- Metformin (SR): Reduces glucose production in the liver and improves insulin sensitivity, ensuring effective utilization of glucose by the body.
This powerful combination ensures steady blood sugar control while addressing associated complications.
Directions for Use:
-
Dosage
- Take as prescribed by your healthcare provider. Typically, it is taken once daily with meals to minimize gastrointestinal discomfort.
-
Administration
- Swallow the tablet whole with a glass of water. Do not crush, chew, or break it.
-
Consistency
- Use the medication regularly at the same time each day for optimal results.
-
Lifestyle Integration
- Combine the medication with a balanced diet, regular exercise, and routine blood sugar monitoring for the best outcomes.
While LINALIGLIP DAPAMET is generally well-tolerated, some individuals may experience:
-
Common Side Effects:
- Nausea
- Diarrhea
- Mild urinary tract infections
- Headache
-
Rare Side Effects:
- Low blood sugar (hypoglycemia) when combined with insulin or sulfonylureas
- Increased urination
- Allergic reactions such as rash or swelling
If you experience severe side effects or symptoms like persistent stomach pain, difficulty breathing, or signs of infection, seek immediate medical attention.
Sitagliptin Tablet IP 25 mg
Product Brochure
Dose/Strength | 25 mg |
Packaging Type | Box |
Manufacturer | Steris Healthcare Pvt Ltd |
Usage/Application | Personal |
Shelf Life | 24 months |
Brand Name | ST GLIPTIN 25 |
ST GLIPTIN 25 is a pharmaceutical product containing Sitagliptin, an effective medication used to control blood sugar levels in individuals with Type 2 diabetes mellitus. It belongs to a class of drugs known as DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors). This medication is often prescribed in combination with other antidiabetic drugs or diet and exercise plans to help manage blood sugar levels and reduce the risk of complications associated with diabetes, such as heart disease, nerve damage, and kidney problems.
Key Ingredients:
- Sitagliptin Tablet IP 25 mg: The active ingredient Sitagliptin works by increasing the levels of incretin hormones, which help regulate insulin production in response to meals. It also lowers the amount of glucose produced by the liver.
- Effective Blood Sugar Control: ST GLIPTIN 25 helps to manage blood sugar levels in adults with Type 2 diabetes, especially when used alongside proper diet and exercise.
- Minimal Risk of Hypoglycemia: Unlike some other diabetes medications, Sitagliptin generally does not cause hypoglycemia (low blood sugar) when used alone.
- Promotes Healthy Insulin Levels: Sitagliptin helps enhance the body’s natural release of insulin after meals, improving overall glucose management.
- Supports Heart Health: Maintaining stable blood sugar levels can reduce the risk of cardiovascular complications, making it an important part of a diabetes management plan.
ST GLIPTIN 25 (Sitagliptin) works by inhibiting the DPP-4 enzyme, which is responsible for breaking down incretin hormones. These hormones play a key role in regulating blood glucose levels by stimulating insulin release and decreasing glucose production in the liver. By inhibiting DPP-4, Sitagliptin increases the levels of active incretin hormones, leading to better control over blood sugar levels, especially after meals.
Directions for Use:
- Dosage: The recommended dose is typically 25 mg taken once daily, as directed by your healthcare provider. This dosage may be adjusted based on the individual's health condition and response to treatment.
- Method: ST GLIPTIN 25 can be taken with or without food. Swallow the tablet whole with a glass of water. To achieve the best results, it's important to take the medication at the same time each day.
- Consistency: It's essential to continue taking ST GLIPTIN 25 as prescribed, even if you feel well. Do not stop the medication without consulting your doctor.
While ST GLIPTIN 25 is generally well-tolerated, some individuals may experience side effects such as:
- Nausea or diarrhea
- Headache
- Upper respiratory tract infections
- Sore throat
- Joint pain
Dapagliflozin 10mg and pioglitazone 15mg tablets
Product Brochure
Strength | 25mg |
Pack Type | Strips |
Brand Name | GLIDAPA PIO |
Manufacturer | Steris Healthcare Pvt Ltd |
Usages | As directed by the physician |
Composition | Dapagliflozin 10mg and pioglitazone 15mg tablets |
Shelf Months | 24 months |
Country of Origin | Made in India |
Key Ingredients:
- Dapagliflozin (10mg) is an SGLT2 inhibitor that lowers blood glucose by increasing glucose excretion via urine.
- Pioglitazone (15mg) is a thiazolidinedione that improves insulin sensitivity in muscle, fat, and liver tissues, thereby increasing glucose utilization.
- Helps to improve glycemic control in Type 2 Diabetes Mellitus.
- Reduces insulin resistance and improves glucose uptake in peripheral tissues.
- Increases urinary glucose excretion, which aids in blood sugar reduction.
- Dapagliflozin's glucose-lowering effect helps with weight management.
- Provides cardiovascular benefits by lowering the risk of heart failure hospitalization.
- Provides renal protection by lowering albuminuria and slowing kidney disease progression.
- Improves lipid profile and aids in managing metabolic syndrome components.
GLIDAPA PIO has a dual mechanism of action.
- Dapagliflozin inhibits SGLT2 in the proximal renal tubules, reducing filtered glucose reabsorption and increasing urinary glucose excretion, which lowers plasma glucose levels.
- Pioglitazone activates PPAR-γ, improving insulin sensitivity in adipose tissue, skeletal muscle, and liver. This leads to improved glucose uptake and reduced hepatic glucose output.Together, they provide complementary benefits for blood sugar management and insulin resistance.
- Take GLIDAPA PIO exactly as directed by your healthcare provider.
- Usually taken once a day, with or without food, and ideally at the same time every day.
- Avoid crushing or chewing the tablet; instead, swallow it whole with a glass of water.
- To achieve the best results, follow your doctor's diet, exercise, and lifestyle recommendations.
- Follow your doctor's advice and monitor your blood glucose levels on a regular basis.
- Do not discontinue or change the dosage without first consulting your physician.
- Common side effects include urinary tract infections, genital infections, increased urination, weight gain (due to pioglitazone), and edema (fluid retention).
- Possible gastrointestinal symptoms include nausea, diarrhea, and stomach discomfort.
- There is a risk of hypoglycemia when combined with insulin or sulfonylureas.
- Rare but serious side effects include heart failure exacerbation, bone fractures, bladder cancer risk (associated with long-term pioglitazone use), and ketoacidosis (though uncommon).
- If you experience symptoms such as shortness of breath, sudden weight gain, or painful urination, contact your doctor immediately.
Linagliptin 5 mg
Minimum Order Quantity: 1 Stripe
Strength | 5 mg |
Form | Tablets |
Composition | Linagliptin (5 mg) |
Packaging Size | ( 6x10 ) |
Brand | LINALIGOLD 5 |
Prescription/Non prescription | Prescription |
Also gives | Pharmaceutical Third Party Manufacturing |
Country of Origin | Made in India |
LinaglipLinagliptin 5 mg
linagliplinagliptin 5 mg improve glycemic control in adults with type 2 diabetes.Linagliptin 5 mg
is often prescribed when diet and exercise alone are insufficient to control blood sugar levels. Linagliptin 5 mg
can be used alone or in combination with other antidiabetic medications such as metformin, sulfonylureas, or insulin.Linagliptin 5 mg
typical dose of Linagliptin is 5 mg taken once daily. Linagliptin can be taken with or without food. Linagliptin 5 mg
is important to take it at the same time each day to maintain consistent blood levels of the medication.Linagliptin works by inhibiting the DPP-4 enzyme, which leads to increased levels of incretin hormones (GLP-1 and GIP). Linagliptin 5 mg
hormones help to:
- Increase insulin secretion from the pancreas in response to meals.
- Decrease the release of glucagon, which lowers the amount of glucose produced by the liver Patients with a history of pancreatitis should use Linagliptin with caution. Unlike many other antidiabetic drugs, Linagliptin does not require dose adjustment in patients with renal impairment.Linagliptin 5 mg
risk of hypoglycemia increases when Linagliptin is used in combination with insulin or sulfonylureas.Patients should discontinue Linagliptin immediately if they experience signs of hypersensitivity. Concomitant use may increase the risk of hypoglycemia.Linagliptin 5 mg
can decrease the effectiveness of Linagliptin by increasing its metabolism.Linagliptin can be safely combined with other antidiabeticmedications, but careful monitoring is necessary to avoid adverse effects.Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
Metformin (850mg) & Linagliptin 2.5mg
Minimum Order Quantity: 1 Box
Strength | 2.5 mg/850 mg |
Pack Type | Box |
Brand | LINALIGOLD M 2.5/850 |
Manufacturer | steris healthcare pvt ltd |
Prescription/Non Prescription | Prescription |
Prescription / Non Prescription | Prescription |
Country of Origin | Made in India |
Metformin (850mg) & Linagliptin 2.5mg
The primary use of this combination is to improve glycemic control in adults with type 2 diabetes. It is usually prescribed when diet, exercise, and single-agent therapy do not provide adequate glycemic control. Metformin works by reducing the amount of sugar produced by the liver, while Linagliptin helps the pancreas release more insulin and decreases the amount of sugar made by the body.Dosage may be adjusted based on individual patient needs, response to treatment, and tolerability. Always follow the prescription guidelines provided by the healthcare provider.: Gastrointestinal issues such as nausea, vomiting, diarrhea, abdominal pain, and a metallic taste in the mouth are commonly reported. Headaches and upper respiratory tract infections are also possible.Lactic acidosis (a rare but serious complication associated with Metformin), pancreatitis, severe allergic reactions, and hypoglycemia when used with other antidiabetic medications. Regular monitoring of kidney function is crucial as Metformin can affect renal function. Patients should also be aware of signs of lactic acidosis, such as muscle pain, difficulty breathing, and abdominal pain.The combination provides a synergistic effect that enhances blood glucose control more effectively than either medication alone.Unlike some diabetes medications, this combination is weight neutral and may even contribute to modest weight loss.Combining two medications into one tablet improves adherence to treatment and simplifies the medication regimen.Decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. Inhibits DPP-4, an enzyme that destroys the incretin hormones GLP-1 and GIP. By protecting these hormones, Linagliptin increases insulin release in response to meals and decreases the amount of glucose produced by the liver.Patients with severe renal impairment or dysfunction should not use this medication due to the risk of lactic acidosis with Metformin. Patients with a known hypersensitivity to Metformin, Linagliptin, or any component of the formulation should avoid this medication. Conditions such as diabetic ketoacidosis should be managed appropriately before considering this medication.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
Glimepiride 1 Mg Tablets
Product Brochure
Form | Tablets |
Packaging type | Box |
Composition | Glimepiride (1 mg) |
Packaging Size | 10x30 |
Brand | GLIMITERIS 1 |
Packaging Type | Blister |
Manufacturer | Steris Healthcare Pvt Ltd |
Brand | GLIMITERIS 1 - Steris Healthcare Pvt Ltd |
Usage | To treat type 2 diabetes |
Prescription/Non Prescription | Prescription |
Also gives | PCD Pharma Franchise |
Country of Origin | Made in India |
Glimepiride 1 mg
Glimiteris 1 mg is an oral diabetes medication that helps control blood sugar levels. Glimiteris 1 mg belongs to a class of drugs called sulfonylureas, which work by stimulating the pancreas to produce more insulin. It's typically prescribed for individuals with type 2 diabetes to help lower their blood sugar levels.
Gliclazide IP (40 Mg), Metformin Hydrochloride IP (500 Mg), Voglibose IP (0.3 Mg)
Product Brochure
Strength | 0.3 mg |
Form | Tablets |
Composition | Gliclazide IP (40 mg), Metformin Hydrochloride IP (500 mg), Voglibose IP (0.3 mg) |
Packaging Size | For 15 tablets |
Packaging Type | alu alu |
Brand | Steris Healthcare Pvt Ltd |
Prescription/Non prescription | Prescription |
Country of Origin | Made in India |
GLICLAGLAZE TRIO 40/0.3 is a prescription medication used for managing type 2 diabetes. It contains a combination of three active ingredients—Gliclazide IP (40 mg), Metformin Hydrochloride IP (500 mg), and Voglibose IP (0.3 mg)—each targeting different pathways to help control blood sugar levels.
Key Benefits:
- Provides comprehensive blood sugar control for patients with type 2 diabetes.
- Reduces fasting and post-meal glucose levels.
- Lowers the risk of complications associated with high blood sugar, such as cardiovascular issues and neuropathy.
- Gliclazide enhances insulin secretion from the pancreas.
- Metformin decreases glucose production in the liver and improves insulin sensitivity.
- Voglibose slows the breakdown of carbohydrates in the intestines, minimizing sudden spikes in blood sugar levels after meals.
- Take this medication as directed by your healthcare provider, typically once or twice daily with meals.
- Swallow the tablet whole with water.
- Do not crush or chew the tablet.
- Regularly monitor your blood sugar levels as advised by your doctor.
- Common: Nausea, diarrhea, stomach pain, and low blood sugar (hypoglycemia).
- Less Common: Headaches, dizziness, and mild gastrointestinal discomfort.
- Rare but Severe: Severe hypoglycemia, lactic acidosis (with metformin), or allergic reactions.